Harrow Health (HROW) Tops Q3 EPS by 9c

Harrow Health (NASDAQ: HROW) reported Q3 EPS of $0.33, $0.09 better than the analyst estimate of $0.24. Revenue for the quarter came in at $71.6 million versus the consensus estimate of $73.69 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
• Snail, Inc. (SNAL) Reports Q3 Loss of $0.36
• Optex Systems Holdings, Inc. (OPXS) Misses Q3 EPS by 2c